Merck
Apr 26, 2012 at 14:56 | Source: Reuters
Apr 12, 2012 at 19:52 | Source: Reuters
Mar 21, 2012 at 03:52 | Source: Reuters
Mar 14, 2012 at 12:56 | Source: Moneycontrol.com
Mar 09, 2012 at 19:16 | Source: PTI
Videos »
News across the web »
May 26, 2012 at 08:21 | Source: Forbes
May 26, 2012 at 00:00 | Source: Wall Street Journal
May 26, 2012 at 00:00 | Source: Bloomberg
May 26, 2012 at 00:00 | Source: Business Week
May 24, 2012 at 02:51 | Source: Forbes
Interact & exchange stock tips & market info »
Related News »
(AP) TRENTON, N.J. -Merck & Co. (MRK) CEO Kenneth Frazier told company shareholders on Tuesday that 2012 and 2013 will be difficult years, but he's confident the company can weather them. Speaking at the company's annual meeting, Frazier noted ...
May 22, 2012 at 15:10 | Source: CBS News
WHITEHOUSE STATION, N.J., May 25, 2012 (BUSINESS WIRE) -- Merck (NYSE:MRK) , known as MSD outside the United States and Canada, welcomes today's launch in Rwanda of Africa's first national rotavirus vaccination program with ROTATEQ(R) (rotavirus ...
May 25, 2012 at 10:41 | Source: Marketwatch
Shares of Merck & Co. (MRK), the second-largest U.S. drugmaker, have been on a bit of a swoon lately showing weakness even on a broad market rally like Monday. Merck is a global research-driven company that develops and manufactures a range of innovative ...
May 22, 2012 at 12:39 | Source: Seekingalpha.com
Amylin Pharmaceuticals Inc. (AMLN), the diabetes drugmaker that has put itself up for sale, received offers from Sanofi (SAN) and Merck & Co. in an initial round of bidding, said three people familiar with the process. The companies made bids of ...
May 26, 2012 at 09:29 | Source: Bloomberg
Merck KGaA 's ( MKGAF) first quarter 2012 earnings per American Depository Receipt (ADR) of $2.19 missed the Zacks Consensus Estimate of $2.35 and the year-ago earnings of $2.61. Higher expenses coupled with exchange rate fluctuation led to the ...
May 15, 2012 at 13:59 | Source: NASDAQ
(RTTNews) - Merck KGaA (MKGAY.PK: News ) said its Executive Board of decided on an outlook until 2014 for the Merck Group. Assuming an unchanged economic environment and currency exchange rates similar to the 2011 average (EUR/USD = 1.35; EUR/CHF = 1.20 ...
May 15, 2012 at 08:52 | Source: RTT News
Merck KGaA’s (MKGAF) first quarter 2012 earnings per American Depository Receipt (ADR) of $2.19 missed the Zacks Consensus Estimate of $2.35 and the year-ago earnings of $2.61. Higher expenses coupled with exchange rate fluctuation led to the decline in ...
May 15, 2012 at 11:58 | Source: Zacks.com
Merck (MRK) recently announced that the U.S. Food and Drug Administration (:FDA) approved a label update for its HIV therapy, Isentress. The FDA has allowed Merck to update Isentress’ label so that 156-week data from the ongoing STARTMRK study ...
May 24, 2012 at 22:03 | Source: Yahoo Finance
Merck KGaA (MKGAF) recently reported disappointing interim data from a late-stage study (PETACC-8) on Erbitux (cetuximab), which is being evaluated as an adjuvant treatment of stage III colon cancer. The data did not support the use of the drug for the ...
May 17, 2012 at 16:34 | Source: Zacks.com
Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company that discovers, develops, manufactures and sells pharmaceuticals and vaccines for human and animal healthcare markets. The company manufactures pharmaceutical products in various ...
May 19, 2012 at 16:25 | Source: Transworld News
















